These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11824552)

  • 21. Dephosphorylation of cancer protein by tyrosine phosphatases in response to analogs of luteinizing hormone-releasing hormone and somatostatin.
    Lee LT; Schally AV; Liebow C; Lee PP; Lee PH; Lee MT
    Anticancer Res; 2008; 28(5A):2599-605. PubMed ID: 19035284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ethyl side-chain modifications in novel flexible antiestrogens--design, synthesis and biological efficacy in assay against the MCF-7 breast tumor cell line.
    Meegan MJ; Hughes RB; Lloyd DG; Williams DC; Zisterer DM
    Anticancer Drug Des; 2001 Feb; 16(1):57-69. PubMed ID: 11762645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antagonists of growth hormone-releasing hormone and somatostatin analog RC-160 inhibit the growth of the OV-1063 human epithelial ovarian cancer cell line xenografted into nude mice.
    Chatzistamou I; Schally AV; Varga JL; Groot K; Armatis P; Busto R; Halmos G
    J Clin Endocrinol Metab; 2001 May; 86(5):2144-52. PubMed ID: 11344219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
    Schally AV; Redding TW
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7275-9. PubMed ID: 2890164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of receptors for somatostatin in various tumors using different analogs.
    Srkalovic G; Cai RZ; Schally AV
    J Clin Endocrinol Metab; 1990 Mar; 70(3):661-9. PubMed ID: 1968467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms.
    Buscail L; Estève JP; Saint-Laurent N; Bertrand V; Reisine T; O'Carroll AM; Bell GI; Schally AV; Vaysse N; Susini C
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1580-4. PubMed ID: 7878022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
    Di Marzo V; Melck D; Orlando P; Bisogno T; Zagoory O; Bifulco M; Vogel Z; De Petrocellis L
    Biochem J; 2001 Aug; 358(Pt 1):249-55. PubMed ID: 11485574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A somatostatin analogue inhibits MAP kinase activation and cell proliferation in human neuroblastoma and in human small cell lung carcinoma cell lines.
    Cattaneo MG; Amoroso D; Gussoni G; Sanguini AM; Vicentini LM
    FEBS Lett; 1996 Nov; 397(2-3):164-8. PubMed ID: 8955339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatostatin analog RC-160 inhibits the growth of human osteosarcomas in nude mice.
    Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K
    Int J Cancer; 1996 Mar; 65(6):870-4. PubMed ID: 8631606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters.
    Szepeshazi K; Schally AV; Cai RZ; Radulovic S; Milovanovic S; Szoke B
    Cancer Res; 1991 Nov; 51(21):5980-6. PubMed ID: 1682039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity relationship studies of novel somatostatin analogs with antitumor activity.
    Kéri G; Mezô I; Vadász Z; Horváth A; Idei M; Vántus T; Balogh A; Bökönyi G; Bajor T; Teplán I
    Pept Res; 1993; 6(5):281-8. PubMed ID: 7903057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.
    Plonowski A; Schally AV; Letsch M; Krupa M; Hebert F; Busto R; Groot K; Varga JL
    Prostate; 2002 Aug; 52(3):173-82. PubMed ID: 12111694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiproliferative effect of somatostatin and analogs.
    Bousquet C; Puente E; Buscail L; Vaysse N; Susini C
    Chemotherapy; 2001; 47 Suppl 2():30-9. PubMed ID: 11275700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel antitumor peptide hormones and their effect on signal transduction.
    Kéri G; Balogh A; Horváth A; Mezö I; Vadász Z; Bökönyi G; Bajor T; Vántus T; Teplán I; Horváth J
    J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):105-10. PubMed ID: 1356011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of somatostatin analogues on proliferation of murine colonic cancer cells in vitro.
    Pawlikowski M; Kunert-Radek J; Winczyk K
    Cytobios; 1997; 89(358-359):183-7. PubMed ID: 9418016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatostatin analogs: angiogenesis inhibitors with novel mechanisms of action.
    Woltering EA; Watson JC; Alperin-Lea RC; Sharma C; Keenan E; Kurozawa D; Barrie R
    Invest New Drugs; 1997; 15(1):77-86. PubMed ID: 9195291
    [No Abstract]   [Full Text] [Related]  

  • 37. Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells.
    Hoosein NM; Logothetis CJ; Chung LW
    J Urol; 1993 May; 149(5):1209-13. PubMed ID: 8097794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting peptides for pleural cavity tumor radiotherapy: specificity and dosimetry of Re-188-RC-160.
    Zamora PO; Bender H; Knapp FF; Rhodes BA; Biersack HJ
    Hybridoma; 1997 Feb; 16(1):85-91. PubMed ID: 9085134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of somatostatin and its analogue on proliferation of human epidermoid carcinoma cells in vitro.
    Kamiya Y; Ohmura E; Arai M; Fujii T; Hayakawa F; Ito J; Kawaguchi M; Tsushima T; Sakuma N
    Biochem Biophys Res Commun; 1993 Feb; 191(1):302-7. PubMed ID: 8095388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
    Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
    Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.